TSPO and ovarian neoplasm: Protoporphyrin IX expression, an endogenous ligand of TSPO [36], has been demonstrated in aggressive ovarian tumors [37] and has been used as a phototherapeutic target in conjunction with 2-aminolevulenic acid [38].